Search
Insilico Medicine gets CSRC filing for Hong Kong stock IPO
2025-12-09 /
Read about 0 minute
Author：小编
On December 9, 2025, the International Cooperation Department of the China Securities Regulatory Commission (CSRC) issued a filing notification regarding Insilico Medicine's overseas issuance and listing. The company plans to issue no more than 108,894,000 ordinary shares for overseas listing and get listed on the Hong Kong Stock Exchange.
-
C114 Communication Network -
Communication Home
7 X 24 Track global technological trends
